Davion Healthcare Plc Redomiciles Headquarters to Cork, Ireland
Davion Healthcare Plc, the public company specializing in non-invasive medical technologies, today announced that it has redomiciled its corporate headquarters from Limassol, Cyprus, to Cork, Ireland.
Establishing its headquarters in Ireland provides closer alignment with Davion’s core EU and US markets, where the company will continue to develop and register proprietary, non-invasive monitoring tools for early-stage identification of various medical anomalies including cancer.
Davion’s product portfolio includes BreastCheck™, its FDA-registered at-home breast health screening test that uses a thermosensitive patch and companion mobile app to help detect potential anomalies early, alongside a pipeline of additional non-invasive screening tools, including FootFlow™, Testic™, and ThermaDerm™
About Davion
Davion Healthcare Plc (www.davionhealthcare.com) is a medical technology company developing non-invasive home tests for early-stage identification of various medical anomalies including cancer.
Its lead product, BreastCheck™, is an FDA-registered at-home breast health screening test that uses a thermosensitive patch and companion mobile app to help detect potential anomalies early and without the need for a clinical visit.
Davion operates a capital-light, licensing-led model, designing and registering proprietary monitoring tools, while partnering with third parties for manufacturing and distribution.